Search results
...Data from Phase 2 Study of Pegcetacoplan in Post-Transplant Recurrence of C3G and IC-MPGN...
Morningstar· 3 days ago“It is exciting to see that treatment with pegcetacoplan rapidly reduced disease activity in only 12 weeks, and the effects were sustained over the long term,” said Fadi Fakhouri, M.D., Ph.D ...
Earnings call: Photronics posts steady Q2 sales despite challenges By Investing.com
Investing.com· 4 days agoThe company experienced a slight disruption, with a $3 million reduction in sales attributed to the...
Wennberg scores in OT, Rangers top Panthers 5-4 to take lead in East finals
WJTV Jackson· 14 hours agoSUNRISE, Fla. (AP) — Igor Shesterkin gave the New York Rangers a chance. Alex Wennberg got just...
TSMC struggles to meet demand for CoWoS packaging, holding back AI and HPC chip production: report
Tom's Hardware via Yahoo News· 6 days agoTSMC 3D IC packaging tech. Major cloud service providers (CSPs) — AWS, Google, Meta, and Microsoft —...
China's SMIC ranks as world's third-largest chip foundry by sales in first quarter on back of strong...
South China Morning Post via Yahoo Finance· 4 days agoSemiconductor Manufacturing International Corp (SMIC), mainland China's biggest contract chip maker,...
Photronics (PLAB) Q2 Earnings Miss Estimates, Revenues Fall Y/Y
Zacks via Yahoo Finance· 4 days agoPhotronics (PLAB) second-quarter fiscal 2024 results reflect weakness in the IC and FPD segments due...
Photronics (PLAB) Q2 Earnings Miss Estimates, Revenues Fall Y/Y
Zacks· 4 days agoPhotronics (PLAB) second-quarter fiscal 2024 results reflect weakness in the IC and FPD segments due...
Voltraware Makes a Stellar Debut at VivaTech 2024, Advances to Finals
Morning Times· 3 days agoAmong them, Voltraware secured a spot in the finals of the IC Taiwan Challenge on May 23 during...
Class 1A and 2A softball state finals in Peoria: Tickets, matchups, directions
Peoria Journal Star· 8 hours agoEverything you need to know ahead of the 2024 IHSA Class 1A and 2A softball state finals at...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing...
WROC Rochester· 2 days agoNovartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G...